Capnography Devices Market size was valued at US$ 490 Million in 2021 and is projected to reach US$ 968.5 Million by 2028 at a CAGR of 8.89% during the forecast period 2022 to 2028. Capnography Devices Market growing at a significant rate due to the implementation of regulatory guidelines for procedural sedation and rise in adoption of capnography devices due to higher efficiency and reliability are anticipated to fuel the market. Capnography is the process of monitoring partial pressure or concentration of carbon dioxide in respiratory gases by using capnogram. capnography devices market is majorly used as a monitoring tool during intensive care and anesthesia. Capnography helps to anesthesiologists to prevent the hypoxia and help to determine the situations that can lead to hypoxia and may cause irreversible brain damage. Due to these advantages, capnography is widely used in endoscopic suites, emergency rooms, x-ray rooms, and on-site emergency and trauma centres. In healthy individuals, the difference between the arterial blood and expired CO2 partial pressure is very small, however, in presence of lung disease, and some congenital heart disease the difference is increased and can exceed 1 kPa. Technological advancements in capnography devices, such as Oridion’s micro-stream technology helps in reducing the dispersion of gases in sampling tube and increase in the prevalence of asthma (according to WHO 2013, approximately 235 Mn people suffered from asthma) expected to drive the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by the market players for increasing their revenue. For instance, in October 2013, Covidien, a subsidiary of Medtronic plc launched Capnostream 20p bedside monitor with Covidien’s micro-stream technology.